Dianthus Therapeutics, Inc. (DNTH) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$76.07
Day's range
$84.86

Dianthus Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 8.20 M $799.33 M   5.56% 17.07%
BLACKROCK, INC. 08/07/2026 4.12 M $401.99 M   29.86% 8.59%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 08/24/2026 4.10 M $42.06 M   10,003.25% 8.54%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 3.89 M $379.05 M   200.92% 8.10%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 3.23 M $314.85 M   24.43% 6.72%
FAIRMOUNT FUNDS MANAGEMENT LLC 08/14/2026 2.54 M $247.33 M   0.00% 5.28%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 2.51 M $245.16 M   119.27% 5.24%
STATE STREET CORP 08/07/2026 2.36 M $229.80 M   68.52% 4.91%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.16 M $210.51 M   6.32% 4.50%
AVIDITY PARTNERS MANAGEMENT LP 08/14/2026 2.10 M $205.12 M   0.00% 4.38%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 1.84 M $179.53 M   -5.39% 3.83%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 1.68 M $163.44 M   0.00% 3.49%
FRED ALGER MANAGEMENT, LLC 08/14/2026 1.30 M $126.97 M   12.10% 2.71%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.26 M $122.70 M   37.36% 2.62%
VR ADVISER, LLC 08/14/2026 1.18 M $115.03 M   0.00% 2.46%
UBS GROUP AG 08/13/2026 1.14 M $111.15 M   45.95% 2.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 1.13 M $109.70 M   10.35% 2.34%
JENNISON ASSOCIATES LLC 08/03/2026 1.02 M $99.60 M   110.61% 2.13%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.02 M $99.31 M   -5.32% 2.12%
CITADEL ADVISORS LLC 08/14/2026 974.91 K $95.03 M   -39.46% 2.03%
FRANKLIN RESOURCES INC 08/13/2026 968.98 K $94.46 M   0.08% 2.02%
BAKER BROS. ADVISORS LP 08/14/2026 852.16 K $83.07 M   0.00% 1.77%
ALLIANCEBERNSTEIN L.P. 08/14/2026 834.15 K $70.00 M   -9.93% 1.74%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 800.00 K $77.98 M   100.00% 1.67%
CORMORANT ASSET MANAGEMENT, LP 08/14/2026 750.00 K $73.11 M   -21.05% 1.56%
BRAIDWELL LP 08/14/2026 594.56 K $57.96 M   -33.89% 1.24%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 570.12 K $55.57 M   63.18% 1.19%
AMERIPRISE FINANCIAL INC 08/14/2026 532.00 K $51.86 M   23.97% 1.11%
WOODLINE PARTNERS LP 08/14/2026 500.55 K $48.79 M   15.48% 1.04%
BARCLAYS PLC 08/14/2026 431.75 K $42.09 M   13.74% 0.90%
LORD, ABBETT & CO. LLC 08/14/2026 422.19 K $41.16 M   41.10% 0.88%
BIOIMPACT CAPITAL LLC 08/14/2026 420.00 K $40.94 M   -0.94% 0.87%
NORTHERN TRUST CORP 08/13/2026 411.79 K $40.14 M   35.57% 0.86%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 400.00 K $38.99 M   14.29% 0.83%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 390.00 K $38.02 M   -40.43% 0.81%
GOLDMAN SACHS GROUP INC 08/14/2026 382.16 K $37.25 M   -30.26% 0.80%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 365.96 K $35.67 M   19.82% 0.76%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 365.96 K $35.67 M   100.00% 0.76%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 08/14/2026 362.47 K $35.33 M   0.00% 0.75%
SPRUCE STREET CAPITAL LP 08/13/2026 354.82 K $34.59 M   -4.94% 0.74%
VIVO CAPITAL, LLC 08/14/2026 354.00 K $34.51 M   0.00% 0.74%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 321.50 K $31.33 M   -1.21% 0.67%
WESTFIELD CAPITAL MANAGEMENT CO LP 08/12/2026 314.91 K $30.70 M   100.00% 0.66%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 302.48 K $29.49 M   21.15% 0.63%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 295.27 K $28.78 M   -6.95% 0.61%
FIRST TURN MANAGEMENT, LLC 08/14/2026 285.77 K $27.86 M   29.35% 0.60%
ASSENAGON ASSET MANAGEMENT S.A. 08/21/2026 280.65 K $27.36 M   100.00% 0.58%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 264.69 K $25.80 M   0.00% 0.55%
ARTISAN PARTNERS LIMITED PARTNERSHIP 08/13/2026 258.27 K $25.18 M   -32.41% 0.54%
BANK OF AMERICA CORP /DE/ 08/14/2026 256.83 K $25.04 M   36.05% 0.53%

Dianthus Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 316 institutional investors and hedge funds held shares of Dianthus Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 8.2 M

BlackRock, Inc.: 4.12 M

T. Rowe Price Investment Management, Inc.: 3.89 M

WELLINGTON MANAGEMENT GROUP LLP: 3.23 M

Fairmount Funds Management LLC: 2.54 M

PRICE T ROWE ASSOCIATES INC /MD/: 2.51 M

137.55% of Dianthus Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 70.11 M shares in the last 24 months. This purchase volume represents approximately $5.55 B in transactions.